vcu bar

MaryPeace McRae, PharmD, PhD, BCPS


Assistant Professor
Department of Pharmacotherapy & Outcomes Science

Location:  Smith Building, Room 652B
Phone: (804) 628-5076
Email: mpmcrae@vcu.edu

Mailing Address

School of Pharmacy
Dept of Pharmacotherapy & Outcomes Science

410 N 12th Street
P.O. Box 980533
Richmond, VA 23298-0533
Fax: (804) 828-0343


Area of Focus

  • Drug Transporters
  • Blood brain barrier
  • HIV
  • Alzheimer's Disease
  • NeuroAIDS
  • Drugs of Abuse

Education

  • Pharm.D., (Virginia Commonwealth University, 2000)
  • Ph.D., Pharmaceutical Sciences (University of North Carolina at Chapel Hill, 2005)

Academic Appointments/Professional Experience

  • (2006 - 2011) Assistant Professor, Department of Pharmacology, Kansas City University of Medicine and Biosciences
  • (2011 - 2012) Associate Professor, Department of Pharmacology, Kansas City University of Medicine and Biosciences
  • (2012 - Present) Assistant Professor, Department of Pharmacotherapy and Outcomes Science, VCU School of Pharmacy

Professional and Scholarly Interests

  • American Society of Clinical Pharmacology and Experimental Therapeutics

Publications

  • Recent Publications
    • Clay PG, McRae M, Laurent JP. Safety, Tolerability, and Pharmacokinetics of KP-1461 in Phase I Clinical Studies: A Single Oral Dose Study in Non-HIV-Infected Adults, and a 14-Day Dose-Escalating Study in Highly Antiretroviral-Experienced HIV-Infected Adults, J Int Assoc Physicians AIDS Care, 2011 Jul-Aug; 10(4):232-8.
    • Clay PG, Adiga R, Taylor TAH, Alsup R, Gerk PM, McRae, MP. Postpartum Pharmacokinetics of Peramivir in the Treatment of Influenza H1N1: A Case Report, Obstetrics & Gynecology, 2011 Aug; 118(2 Pt 2):463-7.
    • Hicks C, Clay P, Redfield R, Lalezari J, Liporace R, Ramirez JM, Schneider S, Sension M, DeGruttola V, Hughes J, McRae MP, Laurent JP, Safety, Tolerability and Efficacy of KP-1461 as Monotherapy for 124 Days in Antiretroviral-Experienced, HIV-1-Infected Subjects. AIDS Research and Human Retroviruses, 2012 Jun 28.
    • Dever, SM, Costin BN, Xu R, El-Hage N, Balinang J, Samoshkin A, O’Brien MA, McRae MP, Diatchenko L, Knapp PE, Hauser KF. 2013. Differential expression of the alternatively-spliced OPRM1 isoform MOR-1K in HIV-infected Subjects. AIDS, 2014 Jan 2; 28(1):19-30.
    • Ellis K, Marlin JW, Taylor TA, Fitting S, Hauser KF, Rice G, McRae M. The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model. J Pharm Pharmacol, 2014 Dec 31. [Epub ahead of print]